Purple Biotech Ltd   (PPBT)
Other Ticker:  


Purple Biotech Ltd

PPBT's Financial Statements and Analysis

Purple Biotech Ltd reported break-even for the forth quarter of 2022 compare to earnings per share of $0.00 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.

forth quarter of 2022
Earnings Per Share Revenues
$ 0 $  0 Mill
Unch.     Unch.    

Purple Biotech Ltd 's Revenue fell by 0 % in forth quarter of 2022 (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Purple Biotech Ltd is Expected to report next financial results on March 02, 2024.

More on PPBT's Income Statement

Purple Biotech Ltd 's net income of $21.760 million in the forth quarter of 2022 increased by 17.83 % from net earnings of $18.468 million achieved in IV. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $0.000 million recorded in previous quarter.

More on PPBT's Growth

Purple Biotech Ltd Inventories
PPBT's Cash flow In theforth quarter of 2022 company's net cash flow was $11 million, capital expenditures grew by -77.39%, to $0 millions compare to same quarter a year ago and fell by